Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07547878 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Study acronym: RAPID-CKD
StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrolling by invitation only Show 5 more changesShow less
    • Start date changed from estimate of Apr 30, 2026 to Apr 8, 2026
    • Eligibility criteria expanded, about 24 words
    • Secondary endpoints: details revised at 9 of 15 entries
    • Site contact updated
    • Publications: details revised at 36 of 37 entries
  2. Primary endpoint(s) modifiedv2 Show 7 more changesShow less
    • Trial status changed: Active, Not Recruiting → Not Yet Recruiting
    • Start date: Apr 9, 2026 to Apr 30, 2026
    • Eligibility criteria expanded, about 28 words
    • Secondary endpoints: 1 to 15
    • Study description expanded, about 223 words
    • Site contact updated
    • Study title revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if starting four kidney disease medicines quickly and together (a rapid treatment approach) is safe and works well in people with type 2 diabetes and chronic kidney disease. The main questions it aims to answer are: * Is it safe to start these medicines over a short period of time? * How often do kidney function changes or high potassium levels occur? * Does this approach lower protein in the urine (a sign of kidney damage)? * How many participants are able to stay on all four medicines over 6 months? Researchers will compare this approach to usual care, where medicines are started one at a time over several months. Participants will: Be assigned by chance to either this approach or usual care Start up to four approved kidney medicines over about 8 weeks (rapid treatment approach) or follow standard care Have regular clinic visits and lab tests to check kidney function and potassium levels Be followed for about 6 months
Trial Details
NCT Number NCT07547878
Lead Sponsor Baylor Research Institute
Conditions
(from sponsor)		 Chronic Kidney Disease, Type 2 Diabetes
Related terms Albuminuria, Diabetes Mellitus, Type 2, Hyperkalemia, Renal Insufficiency, Chronic
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov